Antimycobacterial activity of Brazilian Amazon plants extracts
Keywords:
Mycobacterium tuberculosis, microbial resistance, plant extractAbstract
Tuberculosis (TB) is one infectious disease responsible for more than 2 million of deaths worldwide. The increase of TB cases resistant to drugs normally used in treatment has reinforced the necessity of development of new antimicrobials, which should be active to resistant strains and latent bacilli, further it should reduce the treatment duration. Thus fifty-six plants extracts obtained from Brazilian Amazon forest were tested in three strains of Mycobacterium tuberculosis, being one pan-susceptible strain (H37Rv), one isoniazid resistant and one rifampicin resistant. Twenty-nine plants extracts were active against pan-susceptible strain, twenty-four against isoniazid resistant and thirteen against rifampicin resistant. These results indicate the potential of the Brazilian Amazon plants products as source of new antimicrobials.
References
World Health Organization. Global Tuberculosis Control 2011. Available from: http://www.who.int/tb/publications/global_report/2011/gtbr11_full.pdf. Accessed Jan/ 2012.
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Sistema de Informação de Agravos de Notificação. Tuberculose - Casos confirmados notificados no Sistema de Informação de Agravos de Notificação 2011a. Sinan Net. Available from: http://dtr2004.saude.gov.br/sinanweb/. Accessed Feb/2012.
O’brien RJ, Nunn PP. The need for new drugs against tuberculosis – obstacles, opportunities and next steps. American Journal of Respiratory and Critical Care Medicine. 2001; 163: 1055–1058.
Schenkel EP, Gosmann G, Miranda RP, Petrovick PR. Produtos de origem vegetal e o desenvolvimento de medicamentos. In: Farmacognosia: da planta ao medicamento. Editora UFRGS/Editora da UFSC (Ed). Porto Alegre/Florianópolis; 2003. p. 371-400.
Pinto AC, Silva DHS, Bolzani VS, Lopes NP, Epifanio RA. Produtos naturais: atualidade, desafios e perspectivas. Quím. Nova. 2002; 25(Suppl 1): 45 – 61.
Guerra MP, Nodari RO. Biodiversidade: Aspectos biológicos, geográficos, legais e éticos. In Farmacognosia: da planta ao medicamento. Editora UFRGS/Editora da UFSC (Ed). Porto Alegre/Florianópolis; 2003. p. 13-28.
Dias BFS. A implementação da convenção sobre diversidade biológica no Brasil: desafio e oportunidades. Campinas. André Tosello. 1996
Ministério do Meio Ambiente. Dos Recursos Hídricos e da Amazônia Legal. Primeiro relatório nacional para a convenção sobre diversidade biológica. Ministério do Meio Ambiente: Brasília. 1998.
Simões CMO, Schenkel EP. A pesquisa e a produção brasileira de medicamentos a partir de plantas medicinais: a necessária interação da indústria com a academia. Revista brasileira de farmacognosia. 2002; 12:35-40.
Barreiro EJ, Bolzani VS. Biodiversidade: fonte potencial para a descoberta de fármacos. Quim. Nova. 2009; 32:679-688.
Franzblau SG, Witzig RS, Mclauglhlin JC, Torres P, Madico G, Hernandez A, Degnan MT, Cook MB, Quenzer VK, Ferguson RM, Gilman RH. Rapid, Low-Technology MIC Determination with Clinical Mycobacterium tuberculosis Isolates by Using the Microplate Alamar Blue Assay. J. Clin. Microbiol. 1998; 36(2):362-366.
Palomino JC, Martin A, Camacho M, Guerra H, Swings J, Portaels F. Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2002; 46(8): 2720-2722.
Bello IA, Ndukwe GI, Audu OT, Habila JD. A bioactive flavonoid from Pavetta crassipes K. Schum Org Med Chem Lett. 2011; 1:1-14.
Ramos DF, Leitão GG, Costa FN, Abreu L, Villarreal JV, Leitão SG, Said Y, Fernandez LS, Silva PEA. Investigation of the antimycobacterial activity of 36 plant extracts from the brazilian Atlantic Forest. Rev. Bras. Cienc. Farm. 2008; 44:669-674.
Chokchaisiri R, Suaisom C, Sriphota S, Chindaduang A, Chuprajob T, Suksamrarn A. Bioactive Flavonoids of the Flowers of Butea monosperma. Chem Pharm Bull, Tokyo. 2009; 57:428-32.
Alves TMA, Silva AF, Brandão M, Grandi TSM, Smânia EFA, Júnior AS, Zani CL. Biological Screening of Brazilian Medicinal Plants. Mem Inst Oswaldo Cruz, 200; 95: 367-373
Moccelini SK, Silva VC, Ndiaye EA, Sousa Junior PT, Vieira PC. Estudo fitoquímico das cascas das raízes de Zanthoxylum rigidum Humb. & Bonpl. ex Willd (Rutaceae). Quím. Nova. 2009; 32:131-133.
Ferreira MH, Nakayama H, Arias AR, Schinini A, Bilbao NV, Serna E, Lagoutte D, Soriano-Agatón F, Poupon E, Hocquemiller, Fournet A. Effects of canthin-6-one alkaloids from Zanthoxylum chiloperone on Trypanosoma cruzi-infected mice. Journal of Ethnopharmacology, 2007; 109:258–263.
Ambrozin ARP, Mafezoli J, Vieira PC, Fernandes JB, Silva MFGF, Ellena JA, Albuquerque S. New Pyrone and Quinoline Alkaloid from Almeidea rubra and their Trypanocidal Activity. J. Braz. Chem. Soc.2005; 16:434-439
Novais TS, Costa JFO, David JPL, David JM, Queiroz LP, França F, Giulietti AM, Soares MBP, Santos RR. Atividade antibacteriana em alguns extratos de vegetais do semi-árido brasileiro. Rev. Bras. Farmacogn. 2003; 13: 5-8.
Araujo CAC And Leon LL. Biological activities of Curcuma longa L. Mem. Inst. Oswaldo Cruz. 2001; 96: 723-728.
Leitão SG, Castro O, Fonseca EN, Julião LS, Tavares ES, Leo RRT, Veira RC, Oliveira DR, Leitão GG, Martinos V, Sulsens V, Barbosa YAG, Pinheiro DPG, Silva PEA, Teixeira DF, Junior IN, Lourenço MCS. Screening of Central and South American plant extracts for antimycobacterial activity by the Alamar Blue test. Rev. Bras. Farmacogn. 2006; 16: 6-11.
Aguiar JS, Costa MCCD, Nascimento SC, Sena KXFR. Atividade antimicrobiana de Lippia alba (Mill.) N. E. Brown (Verbenaceae). Rev. Bras. Farmacogn. 2008; 18: 436-440.
Ruiz L, Ruiz L, Maco M, Cobos M, Gutierrez-Choquevilca A, Roumy V. Plants used by native Amazonian groups from the Nanay River (Peru) for the treatment of malaria. Journal of Ethnopharmacology. 2011; 133: 917-921
Rasmussen HB, Christesen SB, Kvist LP, Kharazmi A, Huansi AG. Absolute Configuration and Antiprotozoal Activity of Minquartynoic Acid. J. Nat. Prod. 2000; 63(9):1295-1296
Medeiros R, Otuki MF, Avellar MCW, Calixto JB. Mechanisms underlying the inhibitory actions of the pentacyclic triterpene [alpha]-amyrin in the mouse skin inflammation induced by phorbol ester 12-O-tetradecanoylphorbol-13-acetate. European Journal of Pharmacology, 2007; 559(2007): 227-235
Cursino LMC, Santos I, Mariúba LAM, Jeffreys MFL, Lima NM, Oliveira JL, Orlandi PP And Nunez CV. Antibacterial activity of Minquartia guianensis extracts and phytochemical evaluation. Emir. J. Food Agric. 2011; 23(6): 505-510
Cursino LMC, Mesquita ASS, Mesquita DWO, Fernandes CC, Pereira Junior OL, Amaral IL, Nunez CV. Triterpenos das folhas de Minquartia guianensis Aubl. (Olacaceae). Acta Amaz. 2009; 39(1):181-185
Fernandes CC, Cursino LMC, Novaes JAP, Demetrio CA, Pereira Junior OL, Nunez CV, Amaral IL. Salicilatos isolados de folhas e talos de Salix martiana Leyb. (Salicaceae). Quím. Nova. 2009; 32(4): 983-986.
El-Shemy HA, Aboul-Enein AM, Aboul-Enein KM, Fujita K. Willow Leaves’ Extracts Contain Anti-Tumor Agents Effective against Three Cell Types. PLoS ONE. 2007; 2(1): e178
Long ER. The Chemistry and Chemotherapy of Tuberculosis. Williams & Wilkins. In: CHAKRABORTY S, GRUBER T, BARRY CEB, BOSHOFF HI AND RHEE KY Para-Aminosalicylic Acid Acts as an Alternative Substrate of Folate Metabolism in Mycobacterium tuberculosis. Science 1228980. 1958; Published online 1 November 2012
Taniguchi H, Aramaki H, Nikaido Y. Rifampin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS Microbiol Lett, 1996; 144(1): 103-108.
Bodmer T, Zurcher G, Imboden P, Telenti A. Mutation position and type of substitution in the β-subunit of the RNA polymerase influence in vitro of rifamycins in rifampicin-resistant Mycobacterium tuberculosis. J. Antimicrob Chemother, 1995; 35(2):345-348
Pauli GF, Case RJ, Inui T, Wang Y, Cho S, Fischer NH, Franzblau SG. New perspectives on natural products in TB drug research. Life Sciences. 2005; 78(2005): 485-494.
